Cardionova Ltd, a resident company of the Skolkovo Biomedical Cluster, has successfully completed pre-clinical safety and effectiveness studies of its lead compound AHRO-001, which is being developed in partnership with AtheroNova, a public US company, to treat...
Skolkovo Biomedical Cluster Resident "CardioNova", founded with investments from Maxwell Biotech Venture Fund founded with the participation of RVC, announced today enrollment of the first volunteers with mild to moderate hyperlipidemia in a randomized...